Xponance, Inc.

SEC CIK: 0001637541
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

RXDX holding history

Prometheus Biosciences, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXDX overview All 13F holders of RXDX Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of RXDX by Xponance, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−2,011−100.0%	Sold out	Holders
Q1 2023	2,011	$215.8K	<0.1%	+20+1.0%	Added	Holders
Q4 2022	1,991	$219.0K	<0.1%	+1,991	New	Holders